Edition:
United Kingdom

electroCore, Inc. (ECOR.OQ)

ECOR.OQ on NASDAQ Stock Exchange Global Select Market

4.96USD
17 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,015
52-wk High
$20.25
52-wk Low
$4.18

Summary

Name Age Since Current Position

J.P. Errico

2016 Chairman of the Board, Co-Founder, Principal Investor and Chief Science & Strategy Officer

Francis Amato

2016 Chief Executive Officer

Steve Mendez

2016 Co-Founder, Chief Technical Officer

Thomas Errico

Co-Founder, Board Member and Principal Investor

Glenn Vraniak

Chief Financial Officer

Biographies

Name Description

J.P. Errico

Mr. J.P. Errico is the Chairman of the Board, Co-Founder, Principal Investor and Chief Science & Strategy Officer of the Company. JP received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology, and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University. JP trained as a patent attorney in New York, and is the author of a treatise on international intellectual property law. Along with fellow investor and Board Member, Dr. Thomas Errico, Mr. Errico has founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. Products conceived by these companies have generated more than $8 billion in sales to date. He served as the CEO of SpineCore from the inception of the company through to its sale to Stryker in July 2004. JP is a named inventor on more than 125 issued US patents, and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. In addition to his current role as CSSO, he continues also to make significant inventive contributions in all aspects of the company’s key patent portfolios, along with the clinical and market validations of the company’s products and their indications.

Francis Amato

Mr. Francis R. Amato is the Chief Executive Officer of the Company. Prior to joining electroCore Frank spent 22 years within the pharmaceutical industry. Most recently as Vice President of the Specialty Commercial Operations Group, Global Human Health at Merck. Frank has extensive commercial experience previous roles include: Executive Director, Global Business Operations, Schering-Plough, Business Unit Lead, Oncology, Ligand Pharmaceuticals. National Sales Director, Specialty Managed Markets, Pfizer Inc. National Sales Director Hospitals, Pharmacia Corporation. Frank joined The Upjohn Company in 1990 as a sales representative in NYC. Prior to joining the pharmaceutical industry he was a Infantry Medic in the 82nd Airborne Division of the United States Army. Frank received his Executive MBA from Pepperdine University Graziadio School of Management in 2005 and undergraduate degree in Political Science from St. John’s University in 1990.

Steve Mendez

Mr. Steve Mendez is the Co-Founder, Chief Technical Officer of the Company. Steve is a Research and Development executive with 28 years experience driving all phases of product life cycle from concept/patents and design to manufacturing and sales/field support. Previously Vice President of Development with the EBI division of Biomet, Steve was responsible for electronic, bracing, and softgood products in addition to overseeing the development of external and implantable electrical/thermal therapy medical devices. He also established and managed electronic production/test/repair departments at EBI and previous employers. Steve obtained an MSEE from Rensselaer Polytechnic Institute and a BSEE and BA Biology from Lehigh University.

Thomas Errico

Dr. Thomas J. Errico is the Co-Founder, Board Member and Principal Investor of the Company. Dr. Errico is a graduate of the New Jersey College of Medicine. After completing a residency in orthopedic surgery, he completed a yearlong fellowship in spinal surgery in Toronto with Dr. John Kostuik. After his fellowship, Dr. Errico accepted a joint position in the faculties of both Orthopedic Surgery and Neurosurgery at the New York University Medical School. Now a tenured professor in both departments, Dr. Errico is serving as the Chief of Spine Service for both New York University and the Hospital for Joint Diseases. He is an original member of the North American Spine Society, and served as that society’s President for 2004-5. Along with J.P. Errico, he founded several medical device companies, and according to the MedicineLodge 2001 Spinal Implant Intellectual Property Report, is the most prolific surgeon inventor in the field of spine orthopedics. Dr. Errico has been identified as one of the 10 best orthopedic surgeons in the United States. Dr. Errico served on the Board of Directors of SpineCore from its inception to sale. It is expected that Dr. Errico will serve as a primary contributor and advisor to electroCore for the development of the company’s products and their indications.

Glenn Vraniak

Mr. Glenn S. Vraniak is the Chief Financial Officer of the Company. Glenn has been an executive officer in the healthcare sector for over 13 years. Most recently he was the CFO of G&W Laboratories, a mid-cap specialty pharmaceutical company, where he executed the company’s growth strategy by acquiring 2 companies and over 35 products. Prior to that, he was the President of Aprecia Pharmaceuticals, a 3DP technology enabled pharmaceutical company, where he succeeded in developing the company’s commercial strategy in neurology and raising significant capital. From 2003 through 2011, Glenn was the CFO and Head of Strategic Planning for Prasco Laboratories, the fastest growing generic pharmaceutical company in the U.S. for three consecutive years. He also spent time as an Executive VP for GE Capital and subsequently founded Preceptus, his own boutique consulting firm focused on helping small and mid-market companies achieve efficient and scalable growth in the healthcare and technology sectors. Glenn holds an Electronic Engineering Technology degree and a Managerial MBA in Finance from Rutgers University Center for Management Development.

Basic Compensation

Options Compensation